OTEX
Open Text Corporation
OTEX has lower modeled downside risk, despite its lower overall score.
SNDK
Sandisk Corporation
SNDK has the edge over OTEX overall, supported by stronger fundamentals and stronger modeled upside.
OTEX Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| Healthy | |
| Under pressure |
OTEX's profitability and cash flow are currently healthy, and its revenue is stable, but its balance sheet is under pressure.
SNDK Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
SNDK's revenue, profitability, cash flow and balance sheet are all currently strong.
OTEX PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 6.4x | $24.81 | — |
| Current | 9.4x | $24.81 | — |
| Cheap | 14x | $35.71 | +44% |
| Fair | 31x | $83.11 | +235% |
| Expensive | 53x | $139 | +462% |
Historical ranges are pointers, not guarantees.
OTEX has the edge over SNDK in the historical PE scenario, which offers more potential upside but is not a forecast.
SNDK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 3.8x | $937 | — |
| Current | 7.5x | $937 | — |
| Cheap | 17x | $2,173 | +132% |
| Fair | 24x | $3,048 | +225% |
| Expensive | 59x | $7,452 | +695% |
Historical ranges are pointers, not guarantees.
SNDK's PE is 7.5x, but its earnings don't support one, so it isn't a reliable read right now.
OTEX Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Stable | |
| Stable | |
| Weakening | |
| Limited | |
| High |
Analysts expect OTEX's profitability to weaken, with its earnings and revenue holding steady.
SNDK Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| High |
SNDK has the edge over OTEX on the outlook, with more favorable earnings and revenue expectations.
OTEX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.86 | +46% |
| Q3 2026 | $2.64 | +38% |
| Q2 2026 | $2.58 | +56% |
| Q1 2026 | $2.05 | -16% |
| Q4 2025 | $1.70 | -31% |
| Q3 2025 | $1.91 | +10% |
| Q2 2025 | $1.65 | -3.5% |
| Q1 2025 | $2.45 | +295% |
| Q4 2024 | $2.46 | +423% |
OTEX earned $2.64 per share over the past year, up 38% from the year before.
SNDK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $247.30 | +97% |
| Q3 2026 | $125.61 | +$137.63 |
| Q2 2026 | $73.76 | +$85.07 |
| Q2 2025 | -$11.31 | -$6.65 |
SNDK has the edge over OTEX in the latest year-over-year earnings comparison.
OTEX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.2B | -4% |
| Q2 2026 | $1.3B | +2.9% |
| Q1 2026 | $1.3B | +2.2% |
| Q4 2025 | $1.3B | -0.6% |
| Q3 2025 | $1.3B | +1.5% |
| Q2 2025 | $1.3B | -3.8% |
| Q1 2025 | $1.3B | -13% |
| Q4 2024 | $1.3B | -13% |
OTEX's revenue fell from its 2023 peak and has held roughly level since: $1.2B last quarter, down 4% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | -0.7 points |
| Q2 2026 | 24% | +9.8 points |
| Q1 2026 | 16% | -1 points |
| Q4 2025 | 22% | -0.2 points |
| Q3 2025 | 21% | +4.7 points |
| Q2 2025 | 14% | -0.3 points |
| Q1 2025 | 17% | +1 points |
| Q4 2024 | 22% | +5.6 points |
OTEX's operating margin was 20% last quarter, down 0.7 points from the same quarter a year ago.
SNDK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11B | +378% |
| Q2 2026 | $9B | +372% |
| Q1 2026 | $6B | +251% |
| Q4 2025 | $3B | +61% |
| Q3 2025 | $2.3B | +23% |
| Q2 2025 | $1.9B | +8% |
| Q1 2025 | $1.7B | -0.6% |
| Q4 2024 | $1.9B | +13% |
SNDK has the edge over OTEX on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 80% | +72 points |
| Q2 2026 | 78% | +78 points |
| Q1 2026 | 69% | +180 points |
| Q4 2025 | 35% | +25 points |
| Q3 2025 | 7.6% | -9 points |
| Q2 2025 | 0.9% | N/A |
| Q1 2025 | -111% | -122 points |
| Q4 2024 | 10% | +6.6 points |
SNDK has the edge over OTEX on profitability, with a higher operating margin.
OTEX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $138.5M | +37% |
| Q2 2026 | $122M | -1.6% |
| Q1 2026 | $304.9M | -18% |
| Q4 2025 | $279.4M | -8.9% |
| Q3 2025 | $101.2M | +$218.4M |
| Q2 2025 | $124M | -15% |
| Q1 2025 | $373.8M | +7.4% |
| Q4 2024 | $306.7M | +0.4% |
OTEX generated $845M in free cash flow over the past year, down 6.7% from the year before.
SNDK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $6.3B | +1340% |
| Q2 2026 | $7.1B | +14355% |
| Q1 2026 | $3B | +$3B |
| Q3 2025 | $438M | +$636M |
| Q2 2025 | $49M | +$217M |
| Q1 2025 | -$18M | +$23M |
| Q3 2024 | -$198M | -$157M |
SNDK has the edge over OTEX on cash flow, with more consistent year-over-year improvement.
OTEX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -2.9% | -7.3M shares |
| 1 year | -4.6% | -11.7M shares |
| 3 years | -11% | -29.8M shares |
| 5 years | -11% | -31.1M shares |
| Available history | -11% | -29.5M shares |
OTEX has the edge over SNDK on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $30M |
| Q2 2026 | $11.8M |
| Q1 2026 | $247M |
| Q4 2025 | $50M |
| Q3 2025 | $107.6M |
| Q2 2025 | $145.3M |
| Q1 2025 | $114.6M |
| Q4 2024 | $66M |
OTEX spent $339M buying back its own shares over the past year, down 22% from the year before.
SNDK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.6% | -1M shares |
| 1 year | +3.4% | +5M shares |
| 3 years | +6.9% | +10M shares |
SNDK has 154M diluted shares, up 3.4% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $5B |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
OTEX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.2x | Elevated |
| Q2 2026 | 3.2x | Elevated |
| Q1 2026 | 3.6x | Elevated |
| Q4 2025 | 3.6x | Elevated |
| Q3 2025 | 3.8x | Elevated |
| Q2 2025 | 3.9x | Elevated |
| Q1 2025 | 3.7x | Elevated |
| Q4 2024 | 3.7x | Elevated |
OTEX's net debt is about 3.2 years of its operating earnings (EBITDA), down from 3.8 years a year ago.
SNDK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.7x | Net Cash |
SNDK has the edge over OTEX on leverage, with a lower net debt burden relative to earnings.
OTEX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 50.9 | Neutral |
| Stochastic | 57.4 | Neutral |
OTEX's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
SNDK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.2 | Neutral |
| Stochastic | 10.6 | Oversold |
SNDK's weekly RSI is 40 (neutral) and its Stochastic is 11 (oversold).
OTEX PE vs Technology Sector
| Metric | OTEX | Sector median | Relative |
|---|---|---|---|
| PE | 9.4x | 28x | 66% below |
| PE % | 2 | 35 | 33 pts below |
OTEX is trading at 9.4x earnings, a 66% discount to the Technology sector's median of 28x.
SNDK PE vs Technology Sector
| Metric | SNDK | Sector median | Relative |
|---|---|---|---|
| PE | 7.5x | 28x | 73% below |
| PE % | 4 | 27 | 23 pts below |
SNDK has the edge over OTEX on valuation relative to its sector.
OTEX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $24.8 | 0.2% above |
| 20 week MA | $24.2 | 2.5% above |
| 50 week MA | $25.1 | 1.1% below |
| 100 week MA | $27.6 | 10% below |
| 200 week MA | $31.8 | 22% below |
OTEX has stronger trend alignment. OTEX is above 2 of 5 weekly averages versus SNDK above 0 of 3.
SNDK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,317.5 | 29% below |
| 20 week MA | $1,465.4 | 36% below |
| 50 week MA | $1,119.6 | 16% below |
SNDK is in a downtrend: it's below all three of its weekly moving averages, and 16% below its 50-week average.
OTEX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $44.1 | $45.7 | +3.8% |
| 2021 | $45.7 | $47.4 | +3.6% |
| 2022 | $47.4 | $29.0 | -39% |
| 2023 | $29.0 | $42.0 | +45% |
| 2024 | $42.0 | $28.3 | -33% |
| 2025 | $28.3 | $33.5 | +18% |
| 2026 YTD | $33.5 | $24.8 | -26% |
OTEX has finished higher in four of the last six years. It's down 26% so far in 2026.
SNDK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $50.4 | $250.1 | +396% |
| 2026 YTD | $250.1 | $937.5 | +275% |
SNDK has the edge over OTEX on returns for 2026, with the stronger performance.